Genfit SA Stock Xetra
Equities
XUP
FR0004163111
Biotechnology & Medical Research
Sales 2024 * | 82.48M 89.31M | Sales 2025 * | 48.49M 52.51M | Capitalization | 190M 206M |
---|---|---|---|---|---|
Net income 2024 * | 19M 20.57M | Net income 2025 * | -22M -23.82M | EV / Sales 2024 * | 2.29 x |
Net cash position 2024 * | 1.26M 1.36M | Net cash position 2025 * | 32.5M 35.19M | EV / Sales 2025 * | 3.25 x |
P/E ratio 2024 * |
15.2
x | P/E ratio 2025 * |
-26.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 86.86% |
Latest transcript on Genfit SA
Managers | Title | Age | Since |
---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 56 | 18-04-30 |
Founder | 68 | 99-08-31 | |
Thomas Baetz
DFI | Director of Finance/CFO | 50 | 21-04-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 67 | 21-03-03 | |
Founder | 68 | 99-08-31 | |
Founder | 52 | 99-09-14 |
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |